Aortic stenosis and mitral regurgitation: implications for transcatheter valve treatment

被引：11
作者：
Barbanti, Marco [1 ]
Dvir, Danny [1 ]
Tan, John [1 ]
Webb, John G. [1 ]
机构：
[1] Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada
来源：
EUROINTERVENTION | 2013年 / 9卷
关键词：
aortic stenosis; mitral regurgitation; transcatheter aortic valve implantation;
D O I：
10.4244/EIJV9SSA13
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Moderate or severe mitral regurgitation (MR) is a common finding in patients with severe aortic stenosis (AS). The combination may be a relative indication for double valve surgery, particularly when MR is severe, degenerative, associated with left atrial dilation, chronic atrial fibrillation, or mitral annular calcium. However, in patients for whom open surgery is not desirable, TAVI may provide a reasonable therapeutic strategy with an expectation in selected patients that MR may improve, be better tolerated, or be amenable to staged transcatheter mitral interventions. In this paper, we briefly review the surgical experience with concomitant AS and MR and discuss the potential implications of transcatheter-based heart valve techniques in this patient group.
引用
收藏
页码：S69 / S71
页数：3
相关论文
共 52 条
[1]  
Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Barwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., Vahanian A., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease, Eur Heart J., 24, pp. 1231-1243, (2003)
[2]  
Bonow R.O., Carabello B.A., Chatterjee K., De Leon A.C., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S., 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease, J Am Coll Cardiol., 52, pp. e1-e142, (2008)
[3]  
Vahanian A., Alfieri O., Andreotti F., Antunes M.J., Baron-Esquivias G., Baumgartner H., Borger M.A., Carrel T.P., De Bonis M., Evangelista A., Falk V., Lung B., Lancellotti P., Pierard L., Price S., Schafers H.J., Schuler G., Stepinska J., Swedberg K., Takkenberg J., Von Oppell U.O., Windecker S., Zamorano J.L., Zembala M., Guidelines on the management of valvular heart disease (version 2012), Eur J Cardiothorac Surg., 42, pp. S1-S44, (2012)
[4]  
Arom K.V., Nicoloff D.M., Kersten T.E., Northrup W.F., Lindsay W.G., Emery R.W., Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis, J Thorac Cardiovasc Surg., 98, pp. 1008-1015, (1989)
[5]  
Galloway A.C., Grossi E.A., Baumann F.G., LaMendola C.L., Crooke G.A., Harris L.J., Colvin S.B., Spencer F.C., Multiple valve operation for advanced valvular heart disease: Results and risk factors in 513 patients, J Am Coll Cardiol., 19, pp. 725-732, (1992)
[6]  
Edmunds L.H., Clark R.E., Cohn L.H., Grunkemeier G.L., Miller C., Weisel R.D., Guidelines for reporting morbidity and mortality after cardiac valvular operations, Ann Thorac Surg., 62, pp. 932-935, (1996)
[7]  
Debetaz L.F., Ruchat P., Hurni M., Fischer A., Stumpe F., Sadeghi H., Van Melle G., Goy J.J., St. Jude Medical valve prosthesis: An analysis of long-term outcome and prognostic factors, J Thorac Cardiovasc Surg., 113, pp. 134-148, (1997)
[8]  
Mueller X.M., Tevaearai H.T., Stumpe F., Fischer A.P., Hurni M., Ruchat P., Von Segesser L.K., Long-term results of mitral-aortic valve operations, J Thorac Cardiovasc Surg., 115, pp. 1298-1309, (1998)
[9]  
Turina J., Stark T., Seifert B., Turina M., Predictors of the long-term outcome after combined aortic and mitral valve surgery, Circulation., 100, pp. 48-53, (1999)
[10]  
Barreiro C.J., Patel N.D., Fitton T.P., Williams J.A., Bonde P.N., Chan V., Alejo D.E., Gott V.L., Baumgartner W.A., Aortic valve replacement and concomitant mitral valve regurgitation in the elderly. Impact on survival and functional outcome, Circulation., 112, pp. I443-I447, (2005)
123456